MRK logo

Merck & Co (MRK) EBITDA

Annual EBITDA

$20.22 B
+$13.31 B+192.76%

December 1, 2024

Summary

Performance

1-Year Change

+192.76%

3-Year Change

+12.97%

5-Year Change

+77.78%

15-Year Change

+69.2%

MRK EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.76%
MRK annual EBITDA is higher than 99.76% of companies in Healthcare sector

High & Low

All-time High

$24.71 B
MRK annual EBITDA is currently -18.15% below its historical high of $24.71 billion

3-Year Low

$6.91 B
MRK annual EBITDA is currently +192.76% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
MRK previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
MRK next annual earnings announcement has not yet been scheduled

OtherMRKprofitabilitymetrics:

Annual Revenue

$64.17 B
MRK annual revenue is $64.17 billion

Annual Net Income

$17.12 B
MRK annual net profit is $17.12 billion

Annual EBIT

$20.22 B
MRK annual earnings before interest & taxes is $20.22 billion

Annual EPS

$6.74
MRK annual earnings per share is $6.74

Quarterly EBITDA

$4.35 B
-$1.26 B-22.46%

December 1, 2024

Summary

Performance

3-Month Change

-22.46%

1-Year Change

-41.64%

3-Year Change

-37.46%

5-Year Change

-37.46%

MRK Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.66%
MRK quarterly EBITDA is higher than 99.66% of companies in Healthcare sector

High & Low

All-time High

$13.55 B
MRK quarterly EBITDA is currently -67.92% below its historical high of $13.55 billion

3-Year Low

-$4.16 B

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
MRK previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
MRK next earnings announcement is scheduled for Apr 24, 2025

OtherMRKprofitabilitymetrics:

Quarterly Revenue

$15.62 B
MRK quarterly revenue is $15.62 billion

Quarterly Net Income

$3.74 B
MRK quarterly net profit is $3.74 billion

Quarterly EBIT

$4.35 B
MRK quarterly earnings before interest & taxes is $4.35 billion

Quarterly EPS

$1.48
MRK quarterly earnings per share is $1.48

TTM EBITDA

$24.36 B
+$5.12 B+26.61%

December 1, 2024

Summary

Performance

3-Month Change

+26.61%

1-Year Change

+18.33%

3-Year Change

+97.73%

5-Year Change

+97.73%

MRK TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.92%
MRK TTM EBITDA is higher than 99.92% of companies in Healthcare sector

High & Low

All-time High

$24.71 B
MRK TTM EBITDA is currently -1.41% below its historical high of $24.71 billion

3-Year Low

$6.91 B
MRK TTM EBITDA is currently +252.66% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
MRK previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
MRK next earnings announcement is scheduled for Apr 24, 2025

OtherMRKprofitabilitymetrics:

TTM Revenue

$64.17 B
MRK TTM revenue is $64.17 billion

TTM Net Income

$17.12 B
MRK TTM net profit is $17.12 billion

TTM EBIT

$21.06 B
MRK TTM earnings before interest & taxes is $21.06 billion

TTM EPS

$6.73
MRK TTM earnings per share is $6.73

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$20.22 B
MRK annual EBITDA is $20.22 billion

Annual Net Income

$17.12 B
MRK annual net profit is $17.12 billion

Annual Interest Expense

-
MRK annual interest expense value is unknown

Annual Income Tax

$2.80 B
MRK annual income tax is $2.80 billion

Annual D&A

-
MRK annual depreciation & amortization value is unknown

MRK EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+192.8%-41.6%+18.3%
3 y3 years+13.0%-37.5%+97.7%
5 y5 years+77.8%-37.5%+97.7%

MRK EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-5.1%+192.8%-41.6%+204.6%at high+252.7%
5 y5-year-5.1%+192.8%-41.6%+204.6%at high+252.7%
alltimeall time-18.1%+2009.0%-67.9%+204.6%-1.4%+2989.2%

Merck & Co EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$20.22 B(+192.8%)
$4.35 B(-22.5%)
$24.36 B(+26.6%)
Sep 2024
-
$5.61 B(-24.7%)
$19.24 B(-6.5%)
Jun 2024
-
$7.45 B(+7.1%)
$20.58 B(+129.2%)
Mar 2024
-
$6.96 B(-1001.2%)
$8.98 B(+30.0%)
Dec 2023
$6.91 B(-67.6%)
-$772.00 M(-111.1%)
$6.91 B(-43.9%)
Sep 2023
-
$6.95 B(-267.3%)
$12.32 B(+21.3%)
Jun 2023
-
-$4.16 B(-185.1%)
$10.15 B(-49.2%)
Mar 2023
-
$4.88 B(+5.2%)
$19.97 B(-6.3%)
Dec 2022
$21.32 B(+19.1%)
$4.64 B(-3.1%)
$21.32 B(-1.4%)
Sep 2022
-
$4.79 B(-15.5%)
$21.63 B(-6.2%)
Jun 2022
-
$5.67 B(-9.0%)
$23.06 B(+15.1%)
Mar 2022
-
$6.22 B(+25.7%)
$20.05 B(+12.0%)
Dec 2021
$17.90 B(+75.8%)
$4.95 B(-20.4%)
$17.90 B(+55.8%)
Sep 2021
-
$6.22 B(+135.0%)
$11.49 B(+27.9%)
Jun 2021
-
$2.65 B(-35.1%)
$8.99 B(-12.5%)
Mar 2021
-
$4.08 B(-380.3%)
$10.27 B(-7.2%)
Dec 2020
$10.18 B(-10.5%)
-$1.46 B(-139.2%)
$11.06 B(-6.5%)
Sep 2020
-
$3.72 B(-5.3%)
$11.82 B(+2.5%)
Jun 2020
-
$3.92 B(-19.4%)
$11.53 B(-4.5%)
Mar 2020
-
$4.87 B(-807.0%)
$12.07 B(+6.1%)
Dec 2019
$11.37 B(-18.7%)
-$689.00 M(-120.1%)
$11.37 B(-28.3%)
Sep 2019
-
$3.42 B(-23.3%)
$15.87 B(-3.2%)
Jun 2019
-
$4.46 B(+7.0%)
$16.39 B(+5.8%)
Mar 2019
-
$4.17 B(+9.7%)
$15.50 B(+10.8%)
Dec 2018
$13.99 B(+17.1%)
$3.81 B(-3.6%)
$13.99 B(+4.2%)
Sep 2018
-
$3.95 B(+10.6%)
$13.42 B(+21.8%)
Jun 2018
-
$3.57 B(+33.9%)
$11.02 B(-2.0%)
Mar 2018
-
$2.67 B(-17.6%)
$11.24 B(-5.9%)
Dec 2017
$11.95 B(+10.4%)
$3.24 B(+109.7%)
$11.95 B(+37.0%)
Sep 2017
-
$1.54 B(-59.3%)
$8.72 B(-23.6%)
Jun 2017
-
$3.79 B(+12.3%)
$11.41 B(+5.2%)
Mar 2017
-
$3.38 B(>+9900.0%)
$10.84 B(+0.2%)
Dec 2016
$10.82 B(-13.1%)
$9.00 M(-99.8%)
$10.82 B(-19.0%)
Sep 2016
-
$4.23 B(+31.2%)
$13.36 B(+0.8%)
Jun 2016
-
$3.23 B(-3.9%)
$13.26 B(+5.0%)
Mar 2016
-
$3.36 B(+31.9%)
$12.62 B(+1.4%)
Dec 2015
$12.45 B(-49.6%)
$2.54 B(-38.4%)
$12.45 B(-46.9%)
Sep 2015
-
$4.13 B(+59.6%)
$23.45 B(+3.7%)
Jun 2015
-
$2.59 B(-18.6%)
$22.61 B(-5.2%)
Mar 2015
-
$3.18 B(-76.5%)
$23.86 B(-3.4%)
Dec 2014
$24.71 B(+85.3%)
$13.55 B(+311.6%)
$24.71 B(+70.0%)
Sep 2014
-
$3.29 B(-14.1%)
$14.54 B(-1.0%)
Jun 2014
-
$3.83 B(-5.0%)
$14.69 B(+5.2%)
Mar 2014
-
$4.03 B(+19.3%)
$13.96 B(+4.7%)
Dec 2013
$13.33 B(-18.8%)
$3.38 B(-1.9%)
$13.33 B(+1.5%)
Sep 2013
-
$3.44 B(+11.1%)
$13.14 B(-4.9%)
Jun 2013
-
$3.10 B(-9.0%)
$13.81 B(-10.1%)
Mar 2013
-
$3.41 B(+7.0%)
$15.37 B(-6.5%)
Dec 2012
$16.43 B(+6.3%)
$3.19 B(-22.7%)
$16.43 B(-2.6%)
Sep 2012
-
$4.12 B(-11.5%)
$16.86 B(-1.8%)
Jun 2012
-
$4.66 B(+4.1%)
$17.17 B(+6.1%)
Mar 2012
-
$4.47 B(+23.7%)
$16.19 B(+4.7%)
Dec 2011
$15.46 B(+58.5%)
$3.62 B(-18.4%)
$15.47 B(+17.2%)
Sep 2011
-
$4.43 B(+20.6%)
$13.19 B(+16.6%)
Jun 2011
-
$3.67 B(-1.9%)
$11.31 B(+2.7%)
Mar 2011
-
$3.75 B(+179.3%)
$11.01 B(+12.9%)
Dec 2010
$9.75 B(-46.8%)
$1.34 B(-47.4%)
$9.75 B(-40.1%)
Sep 2010
-
$2.55 B(-24.4%)
$16.29 B(-15.8%)
Jun 2010
-
$3.37 B(+35.8%)
$19.34 B(+4.4%)
Mar 2010
-
$2.48 B(-68.5%)
$18.52 B(+1.1%)
Dec 2009
$18.33 B(+55.1%)
$7.88 B(+40.7%)
$18.33 B(+41.7%)
Sep 2009
-
$5.60 B(+119.1%)
$12.93 B(+40.0%)
Jun 2009
-
$2.56 B(+11.8%)
$9.23 B(+0.4%)
Mar 2009
-
$2.29 B(-8.0%)
$9.19 B(-22.2%)
Dec 2008
$11.81 B(+55.3%)
$2.49 B(+30.6%)
$11.81 B(+3.4%)
Sep 2008
-
$1.90 B(-24.3%)
$11.42 B(+2.3%)
Jun 2008
-
$2.51 B(-48.7%)
$11.17 B(+5.4%)
Mar 2008
-
$4.91 B(+134.1%)
$10.60 B(+39.4%)
Dec 2007
$7.61 B(+27.7%)
$2.10 B(+26.8%)
$7.61 B(+19.6%)
Sep 2007
-
$1.65 B(-15.0%)
$6.36 B(+9.3%)
Jun 2007
-
$1.95 B(+1.7%)
$5.82 B(-0.2%)
Mar 2007
-
$1.91 B(+125.2%)
$5.83 B(-2.0%)
Dec 2006
$5.96 B(-21.3%)
$849.20 M(-23.7%)
$5.96 B(-11.7%)
Sep 2006
-
$1.11 B(-43.1%)
$6.74 B(-10.6%)
Jun 2006
-
$1.96 B(-3.7%)
$7.54 B(-0.6%)
Mar 2006
-
$2.03 B(+24.3%)
$7.59 B(+0.2%)
Dec 2005
$7.57 B(-7.8%)
$1.64 B(-14.7%)
$7.57 B(+1.5%)
Sep 2005
-
$1.92 B(-4.4%)
$7.46 B(+0.9%)
Jun 2005
-
$2.00 B(-0.7%)
$7.40 B(-7.5%)
Mar 2005
-
$2.02 B(+32.3%)
$8.00 B(-2.5%)
Dec 2004
$8.21 B
$1.53 B(-17.7%)
$8.21 B(-7.4%)
Sep 2004
-
$1.85 B(-29.0%)
$8.87 B(-9.3%)
DateAnnualQuarterlyTTM
Jun 2004
-
$2.61 B(+17.3%)
$9.78 B(+1.5%)
Mar 2004
-
$2.22 B(+1.9%)
$9.63 B(-2.4%)
Dec 2003
$9.88 B(-4.2%)
$2.18 B(-21.1%)
$9.87 B(-6.2%)
Sep 2003
-
$2.77 B(+12.2%)
$10.52 B(+2.2%)
Jun 2003
-
$2.46 B(+0.1%)
$10.29 B(-2.4%)
Mar 2003
-
$2.46 B(-13.0%)
$10.55 B(-0.4%)
Dec 2002
$10.32 B(-0.9%)
$2.83 B(+11.7%)
$10.59 B(+6.9%)
Sep 2002
-
$2.53 B(-6.9%)
$9.91 B(-4.5%)
Jun 2002
-
$2.72 B(+8.7%)
$10.38 B(-0.1%)
Mar 2002
-
$2.50 B(+16.6%)
$10.39 B(-0.2%)
Dec 2001
$10.41 B(-2.6%)
$2.15 B(-28.5%)
$10.41 B(-7.7%)
Sep 2001
-
$3.01 B(+10.1%)
$11.28 B(+2.5%)
Jun 2001
-
$2.73 B(+8.2%)
$11.00 B(+1.0%)
Mar 2001
-
$2.52 B(-16.2%)
$10.89 B(+1.9%)
Dec 2000
$10.69 B(+18.0%)
$3.01 B(+10.2%)
$10.69 B(+3.8%)
Sep 2000
-
$2.73 B(+4.4%)
$10.30 B(+5.0%)
Jun 2000
-
$2.62 B(+13.0%)
$9.81 B(+4.5%)
Mar 2000
-
$2.32 B(-11.7%)
$9.39 B(+3.6%)
Dec 1999
$9.06 B(+22.5%)
$2.62 B(+16.7%)
$9.06 B(+7.1%)
Sep 1999
-
$2.25 B(+2.4%)
$8.46 B(-1.1%)
Jun 1999
-
$2.20 B(+10.4%)
$8.55 B(+7.7%)
Mar 1999
-
$1.99 B(-1.9%)
$7.94 B(+7.4%)
Dec 1998
$7.39 B(+10.3%)
$2.03 B(-13.4%)
$7.39 B(-4.3%)
Sep 1998
-
$2.34 B(+47.4%)
$7.73 B(+12.8%)
Jun 1998
-
$1.59 B(+10.3%)
$6.85 B(+0.9%)
Mar 1998
-
$1.44 B(-39.0%)
$6.79 B(+1.3%)
Dec 1997
$6.70 B(+13.3%)
$2.36 B(+61.3%)
$6.70 B(+4.0%)
Sep 1997
-
$1.46 B(-4.0%)
$6.44 B(+1.9%)
Jun 1997
-
$1.52 B(+12.7%)
$6.32 B(+3.2%)
Mar 1997
-
$1.35 B(-35.6%)
$6.13 B(+3.7%)
Dec 1996
$5.91 B(+12.3%)
$2.10 B(+56.0%)
$5.91 B(+5.2%)
Sep 1996
-
$1.35 B(+1.1%)
$5.62 B(+2.4%)
Jun 1996
-
$1.33 B(+17.4%)
$5.48 B(+2.3%)
Mar 1996
-
$1.13 B(-37.2%)
$5.36 B(+1.9%)
Dec 1995
$5.26 B(-0.3%)
$1.81 B(+48.9%)
$5.26 B(+0.4%)
Sep 1995
-
$1.21 B(+0.2%)
$5.24 B(+0.0%)
Jun 1995
-
$1.21 B(+17.2%)
$5.24 B(-0.7%)
Mar 1995
-
$1.03 B(-42.2%)
$5.28 B(-0.1%)
Dec 1994
$5.28 B(+22.8%)
$1.79 B(+47.6%)
$5.28 B(+0.2%)
Sep 1994
-
$1.21 B(-2.8%)
$5.27 B(+4.0%)
Jun 1994
-
$1.25 B(+20.2%)
$5.07 B(+25.6%)
Mar 1994
-
$1.04 B(-41.7%)
$4.03 B(+3.8%)
Dec 1993
$4.30 B(+12.8%)
$1.78 B(+76.5%)
$3.89 B(+32.0%)
Sep 1993
-
$1.01 B(+373.8%)
$2.94 B(+4.0%)
Jun 1993
-
$212.40 M(-76.1%)
$2.83 B(-20.3%)
Mar 1993
-
$890.30 M(+6.7%)
$3.55 B(+1.7%)
Dec 1992
$3.81 B(+13.0%)
$834.40 M(-6.5%)
$3.49 B(+1.4%)
Sep 1992
-
$892.80 M(-4.2%)
$3.44 B(+3.1%)
Jun 1992
-
$931.70 M(+11.9%)
$3.34 B(+1.6%)
Mar 1992
-
$832.60 M(+6.1%)
$3.29 B(+1.4%)
Dec 1991
$3.37 B(+16.1%)
$784.50 M(-0.7%)
$3.24 B(+3.4%)
Sep 1991
-
$790.40 M(-10.2%)
$3.14 B(+3.9%)
Jun 1991
-
$880.30 M(+11.9%)
$3.02 B(+6.5%)
Mar 1991
-
$786.50 M(+16.0%)
$2.84 B(+6.9%)
Dec 1990
$2.91 B(+18.2%)
$678.10 M(+0.6%)
$2.65 B(+5.0%)
Sep 1990
-
$673.80 M(-3.3%)
$2.53 B(+3.9%)
Jun 1990
-
$696.80 M(+15.6%)
$2.43 B(-26.8%)
Mar 1990
-
$602.70 M(+9.1%)
$3.32 B(-22.6%)
Dec 1989
$2.46 B(+18.6%)
$552.40 M(-4.7%)
$4.29 B(+258.1%)
Sep 1989
-
$579.60 M(-63.4%)
$1.20 B(-42.6%)
Jun 1989
-
$1.59 B(+0.9%)
$2.09 B(+4.3%)
Mar 1989
-
$1.57 B(-161.9%)
$2.00 B(+7.2%)
Dec 1988
$2.07 B(+31.2%)
-$2.54 B(-272.8%)
$1.87 B(-11.4%)
Sep 1988
-
$1.47 B(-2.1%)
$2.11 B(+8.3%)
Jun 1988
-
$1.50 B(+4.4%)
$1.95 B(+14.8%)
Mar 1988
-
$1.44 B(-162.5%)
$1.69 B(+23.8%)
Dec 1987
$1.58 B(+27.9%)
-$2.30 B(-275.9%)
$1.37 B(-20.8%)
Sep 1987
-
$1.31 B(+4.6%)
$1.73 B(+17.1%)
Jun 1987
-
$1.25 B(+12.4%)
$1.48 B(+19.8%)
Mar 1987
-
$1.11 B(-157.3%)
$1.23 B(+18.2%)
Dec 1986
$1.24 B(+20.8%)
-$1.94 B(-284.0%)
$1.04 B(-15.4%)
Sep 1986
-
$1.05 B(+4.8%)
$1.23 B(+19.2%)
Jun 1986
-
$1.00 B(+9.1%)
$1.03 B(+14.1%)
Mar 1986
-
$921.10 M(-152.6%)
$904.60 M(+7.7%)
Dec 1985
$1.02 B(+6.6%)
-$1.75 B(-304.5%)
$839.80 M(+6.5%)
Sep 1985
-
$855.80 M(-2.5%)
$788.50 M(-0.3%)
Jun 1985
-
$877.40 M(+2.5%)
$790.60 M(-1.7%)
Mar 1985
-
$856.30 M(-147.5%)
$804.50 M(+1.0%)
Dec 1984
$958.80 M
-$1.80 B(-309.9%)
$796.80 M(-69.3%)
Sep 1984
-
$857.90 M(-3.7%)
$2.60 B(+49.3%)
Jun 1984
-
$891.30 M(+5.0%)
$1.74 B(+105.0%)
Mar 1984
-
$848.60 M
$848.60 M

FAQ

  • What is Merck & Co annual EBITDA?
  • What is the all time high annual EBITDA for Merck & Co?
  • What is Merck & Co annual EBITDA year-on-year change?
  • What is Merck & Co quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Merck & Co?
  • What is Merck & Co quarterly EBITDA year-on-year change?
  • What is Merck & Co TTM EBITDA?
  • What is the all time high TTM EBITDA for Merck & Co?
  • What is Merck & Co TTM EBITDA year-on-year change?

What is Merck & Co annual EBITDA?

The current annual EBITDA of MRK is $20.22 B

What is the all time high annual EBITDA for Merck & Co?

Merck & Co all-time high annual EBITDA is $24.71 B

What is Merck & Co annual EBITDA year-on-year change?

Over the past year, MRK annual EBITDA has changed by +$13.31 B (+192.76%)

What is Merck & Co quarterly EBITDA?

The current quarterly EBITDA of MRK is $4.35 B

What is the all time high quarterly EBITDA for Merck & Co?

Merck & Co all-time high quarterly EBITDA is $13.55 B

What is Merck & Co quarterly EBITDA year-on-year change?

Over the past year, MRK quarterly EBITDA has changed by -$3.10 B (-41.64%)

What is Merck & Co TTM EBITDA?

The current TTM EBITDA of MRK is $24.36 B

What is the all time high TTM EBITDA for Merck & Co?

Merck & Co all-time high TTM EBITDA is $24.71 B

What is Merck & Co TTM EBITDA year-on-year change?

Over the past year, MRK TTM EBITDA has changed by +$3.77 B (+18.33%)